• DocumentCode
    2634358
  • Title

    Interleukin-21 as an Effective Suppressant for IgE-mediated Allergic Hypersensitivity Reactions

  • Author

    Kishida, Tsunao ; Hiromura, Yayoi ; Hama, Takemitsu ; Imanishi, Jiro ; Hisa, Yasuo ; Mazda, Osam

  • Author_Institution
    Kyoto Prefectural Univ. of Med., Kyoto
  • fYear
    2007
  • fDate
    11-14 Nov. 2007
  • Firstpage
    304
  • Lastpage
    309
  • Abstract
    IgE plays essential roles in the pathogenesis of many allergic disorders including bronchial asthma, allergic rhinitis, atopic dermatitis, and anaphylaxis. If IgE production can be effectively and safely controlled in patients, such procedures may alleviate allergic symptoms, leading to novel therapeutic and prophylactic interventions of allergic diseases. Interleukin-21 (IL-21) is a cytokine produced by activated T cells. It exerts pleiotrophic immunomodulatory functions through acting on various immune cells including T, B, and NK cells. To analyze influence of exogenous IL-21 in vivo, we inserted an expression unit of IL-21 cDNA into an Epstein-Barr virus (EBV)-based artificial chromosome, so that extremely powerful and long-lasting expression of the cytokine can be achieved in vivo in the liver. Peanut anaphylactic mice were established by repetitive immunization with the crude peanut extract (CPE) as an allergen, and they received intravenous administration of the DNA construct through the tail vein under high pressure. As the results, anaphylactic symptoms were completely abrogated by the IL-21 gene treatment, in striking contrast to untreated allergic mice that showed extremely severe systemic disturbance. Serum level of IgE was also drastically suppressed by IL-21 gene treatment. Then we used recombinant IL-21 (rIL-21) to treat anaphylactic as well as allergic rhinitis mice, which also showed significant remission of the diseases. As the mechanisms of the IgE regulation, we found that expression of germ line Cepsiv transcript was suppressed in B cells that were treated with rIL-21 in vitro or in vivo, suggesting that IL-21 effectively suppressed the class switch recombination (CSR) to IgE. The present findings strongly suggest that IL-21 can be used as a novel molecular medicine to control allergy. It was also shown that the EBV-based artificial chromosome provides a useful means to analyze bioactivity in vivo of various genes in mammals, providing a platfor- m to investigate functions of genes as well as to discover promising molecules for therapeutic molecular targeting to treat various disorders.
  • Keywords
    DNA; biochemistry; cellular biophysics; diseases; genetics; liver; molecular biophysics; patient treatment; proteins; Epstein-Barr virus; IL-21 cDNA expression; IL-21 gene treatment; IgE-mediated allergic hypersensitivity reactions; activated T cells; allergic diseases; allergic rhinitis mice; chromosome; class switch recombination; crude peanut extract; cytokine; gene treatment; immune cells; interleukin-21; liver; molecular medicine; peanut anaphylactic mice; pleiotrophic immunomodulatory functions; prophylactic interventions; suppressant; therapeutic interventions; therapeutic molecular targeting; Biological cells; DNA; Diseases; Immune system; In vivo; Liver; Mice; Pathogens; Production; Switches;
  • fLanguage
    English
  • Publisher
    ieee
  • Conference_Titel
    Micro-NanoMechatronics and Human Science, 2007. MHS '07. International Symposium on
  • Conference_Location
    Nagoya
  • Print_ISBN
    978-1-4244-1858-9
  • Electronic_ISBN
    978-1-4244-1858-9
  • Type

    conf

  • DOI
    10.1109/MHS.2007.4420871
  • Filename
    4420871